These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
360 related items for PubMed ID: 27516211
21. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy. Timonen P, Magga J, Risteli J, Punnonen K, Vanninen E, Turpeinen A, Tuomainen P, Kuusisto J, Vuolteenaho O, Peuhkurinen K. Int J Cardiol; 2008 Mar 14; 124(3):293-300. PubMed ID: 17442428 [Abstract] [Full Text] [Related]
22. TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma. Ulrich D, Noah EM, von Heimburg D, Pallua N. Plast Reconstr Surg; 2003 Apr 01; 111(4):1423-31. PubMed ID: 12618601 [Abstract] [Full Text] [Related]
24. Canine Dilated Cardiomyopathy: Diffuse Remodeling, Focal Lesions, and the Involvement of Macrophages and New Vessel Formation. Gasparini S, Fonfara S, Kitz S, Hetzel U, Kipar A. Vet Pathol; 2020 May 01; 57(3):397-408. PubMed ID: 32125251 [Abstract] [Full Text] [Related]
25. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Klotz S, Foronjy RF, Dickstein ML, Gu A, Garrelds IM, Danser AH, Oz MC, D'Armiento J, Burkhoff D. Circulation; 2005 Jul 19; 112(3):364-74. PubMed ID: 15998679 [Abstract] [Full Text] [Related]
26. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V. Am Heart J; 2008 Jul 19; 156(1):85-91. PubMed ID: 18585501 [Abstract] [Full Text] [Related]
27. Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patients. Picard F, Brehm M, Fassbach M, Pelzer B, Scheuring S, Küry P, Strauer BE, Schwartzkopff B. Clin Res Cardiol; 2006 May 19; 95(5):261-9. PubMed ID: 16598395 [Abstract] [Full Text] [Related]
28. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, Spinale FG. Circulation; 1998 May 05; 97(17):1708-15. PubMed ID: 9591765 [Abstract] [Full Text] [Related]
29. Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure. Koshman YE, Patel N, Chu M, Iyengar R, Kim T, Ersahin C, Lewis W, Heroux A, Samarel AM. J Card Fail; 2013 Apr 05; 19(4):283-94. PubMed ID: 23582094 [Abstract] [Full Text] [Related]
30. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z. J Nephrol; 2007 Apr 05; 20(4):444-52. PubMed ID: 17879211 [Abstract] [Full Text] [Related]
31. Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries. Lipczyńska M, Szymański P, Kumor M, Klisiewicz A, Hoffman P. PLoS One; 2017 Apr 05; 12(8):e0180629. PubMed ID: 28767656 [Abstract] [Full Text] [Related]
32. Characteristic adaptations of the extracellular matrix in dilated cardiomyopathy. Louzao-Martinez L, Vink A, Harakalova M, Asselbergs FW, Verhaar MC, Cheng C. Int J Cardiol; 2016 Oct 01; 220():634-46. PubMed ID: 27391006 [Abstract] [Full Text] [Related]
33. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Klappacher G, Franzen P, Haab D, Mehrabi M, Binder M, Plesch K, Pacher R, Grimm M, Pribill I, Eichler HG. Am J Cardiol; 1995 May 01; 75(14):913-8. PubMed ID: 7733000 [Abstract] [Full Text] [Related]
35. Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy. Yokoseki O, Yazaki Y, Suzuki J, Imamura H, Takenaka H, Isobe M. Jpn Circ J; 2000 May 01; 64(5):352-7. PubMed ID: 10834450 [Abstract] [Full Text] [Related]
36. Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age. Antonov IB, Kozlov KL, Pal'tseva EM, Polyakova OV, Lin'kova NS. Bull Exp Biol Med; 2018 Mar 01; 164(4):550-553. PubMed ID: 29504111 [Abstract] [Full Text] [Related]
37. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants. Ulrich D, Lichtenegger F, Eblenkamp M, Repper D, Pallua N. Plast Reconstr Surg; 2004 Jul 01; 114(1):229-36. PubMed ID: 15220598 [Abstract] [Full Text] [Related]
38. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure. Kaye DM, Khammy O, Mariani J, Maeder MT. Eur J Heart Fail; 2013 Mar 01; 15(3):292-8. PubMed ID: 23143794 [Abstract] [Full Text] [Related]
39. Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology. Yilmaz Y, Eren F. Eur J Gastroenterol Hepatol; 2019 Jan 01; 31(1):43-46. PubMed ID: 30134384 [Abstract] [Full Text] [Related]
40. Abnormal matrix remodeling in adolescents and young adults with Kawasaki disease late after onset. Lin MT, Chen SJ, Ho YL, Huang KC, Chen CA, Chiu SN, Sun LC, Lee WJ, Chen HC, Wang JK, Wu MH. Clin Chem; 2008 Nov 01; 54(11):1815-22. PubMed ID: 18801939 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]